PM

Prosight Management Portfolio holdings

AUM $484M
1-Year Est. Return 19.1%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+19.1%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$416M
AUM Growth
+$6.43M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
50
New
Increased
Reduced
Closed

Top Buys

1
+$23.4M
2
+$9.91M
3
+$8.57M
4
BSX icon
Boston Scientific
BSX
+$7.88M
5
SEM icon
Select Medical
SEM
+$6.94M

Top Sells

1
+$34.3M
2
+$20M
3
+$12.6M
4
ARGX icon
argenx
ARGX
+$12.3M
5
MIRM icon
Mirum Pharmaceuticals
MIRM
+$10.2M

Sector Composition

1 Healthcare 99.88%
2 Industrials 0.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRBP icon
26
Corbus Pharmaceuticals
CRBP
$150M
$4.34M 1.04%
343,400
-236,493
RCKT icon
27
Rocket Pharmaceuticals
RCKT
$542M
$4.13M 0.99%
1,267,965
-312,623
PRCT icon
28
Procept Biorobotics
PRCT
$1.27B
$2.75M 0.66%
+76,991
ALGN icon
29
Align Technology
ALGN
$13.6B
$2.43M 0.58%
+19,442
ARGX icon
30
argenx
ARGX
$47.5B
$2.43M 0.58%
3,300
-18,700
TWST icon
31
Twist Bioscience
TWST
$2.88B
$2.11M 0.51%
+75,000
AKRO
32
DELISTED
Akero Therapeutics
AKRO
$1.86M 0.45%
+39,072
CTMX icon
33
CytomX Therapeutics
CTMX
$910M
$1.8M 0.43%
564,800
-2,952,313
SGHT icon
34
Sight Sciences
SGHT
$273M
$1.51M 0.36%
439,941
-431,746
OKUR
35
OnKure Therapeutics
OKUR
$36.7M
$737K 0.18%
267,959
+108,267
SDGR icon
36
Schrodinger
SDGR
$888M
$699K 0.17%
+34,830
RNTX
37
Rein Therapeutics
RNTX
$30M
$650K 0.16%
567,898
+139,979
TBI
38
Trueblue
TBI
$127M
$487K 0.12%
+79,476
PRTA icon
39
Prothena Corp
PRTA
$467M
$195K 0.05%
20,000
-247,800
PLRX icon
40
Pliant Therapeutics
PLRX
$79.9M
$30.3K 0.01%
20,487
-816,913
ACTU
41
Actuate Therapeutics
ACTU
$86.9M
$5.92K ﹤0.01%
+885
AXGN icon
42
Axogen
AXGN
$1.59B
– –
-282,809
CORT icon
43
Corcept Therapeutics
CORT
$3.8B
– –
0
ERAS icon
44
Erasca
ERAS
$4.23B
– –
-240,295
LIVN icon
45
LivaNova
LIVN
$3.86B
– –
-140,000
LNTH icon
46
Lantheus
LNTH
$4.97B
– –
-34,576
MIRM icon
47
Mirum Pharmaceuticals
MIRM
$5.53B
– –
-200,000
MURA
48
DELISTED
Mural Oncology
MURA
– –
-900,000
PEPG icon
49
PepGen
PEPG
$428M
– –
-243,980
UNH icon
50
UnitedHealth
UNH
$266B
– –
-110,000
1
2